semaglutide biomarkers alzheimer Alzheimer's disease: use linked to lower risk Exploring the Impact of Semaglutide

This review describes the regulatory mechanism of neuronal GSH production and its potential therapeutic application in the treatment of neurodegenerative diseases

The primary methods are subcutaneous (just under the skin), intramuscular (into the muscle), and intravenous (into a vein)

Pregnancy and Breastfeeding Risks : The safety of Ozempic during pregnancy and breastfeeding has not been fully established

Injections should be administered following clinical assessment, and long-term or repeated use should be medically guided

This was because other GLP-1 analogues, such as dulaglutide and loxenatide, were only used in overweight/obese BMI trials